Several membrane receptors, including EGFR, interact with amyloid β (Aβ), raising the possibility that erlotinib could have therapeutic effects on Alzheimer's disease (AD). The gene discussed is EGFR; the disease is early-onset autosomal dominant Alzheimer disease.